US Health Secretary Robert F Kennedy Jr said the country is pulling its support from the vaccines alliance Gavi, saying the organisation has ignored the science and lost the public trust.
A video of Kennedy's speech was shown to participants at a Gavi meeting in Brussels on Wednesday, where the vaccines group was hoping to raise at least $9 billion for the next five years.
Gavi is a public-private partnership including WHO, UNICEF, the Gates Foundation and the World Bank. It has paid for more than 1 billion children to be vaccinated through routine immunisation programmes, saving an estimated 18 million lives. The US has long been one of its biggest supporters; before Trump's re-election, the country had pledged $ 1 billion through 2030.
Kennedy called on Gavi to re-earn the public trust and to justify the $ 8 billion America has provided in funding since 2001, saying officials must consider the best science available, even when that science contradicts established paradigms. Kennedy said until that happens, the US won't contribute further to Gavi.
Kennedy, a longtime vaccine sceptic, said he and President Trump were concerned about how Gavi and the World Health Organisation partnered together during the COVID-19 pandemic to work with social media companies to silence dissenting views, to stifle free speech and legitimate questions during a time when many people had questions about vaccine safety.
Kennedy said Gavi continues to make questionable recommendations, like advising pregnant women to get immunized against COVID-19 and funding the roll-out of a vaccine against diphtheria, tetanus and pertussis in poorer countries.
WHO and other health authorities have recommended pregnant women get vaccinated against COVID-19, saying they are at higher risk of severe disease.
Kennedy said he has seen research that concluded that young girls vaccinated against diphtheria, tetanus and pertussis were more likely to die from all other causes than children who weren't immunized.
Gavi said in a statement Thursday that its utmost concern is the health and safety of children. The organisation said any decision it makes on vaccines to buy is done in accordance with recommendations issued by WHO's expert vaccine group.
This ensures Gavi investments are grounded in the best available science and public health priorities, it said. Gavi said scientists had reviewed all available data, including any studies that raised concerns, and that the diphtheria, tetanus and pertussis vaccine has played a key role in helping halve childhood mortality.
The British government said Wednesday it would give 1.25 billion pounds ($ 1.7 billion) between 2026 and 2030 to Gavi. It said the money would help Gavi protect up to 500 million children in some of the world's poorest countries from diseases including meningitis, cholera and measles.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)